| 000 | 01557nam a2200349 a 4500 | ||
|---|---|---|---|
| 001 | 00059309 | ||
| 003 | OSt | ||
| 005 | 20150307112214.0 | ||
| 008 | 110513s1992 nyua b 001 0 eng | ||
| 010 | _a91030971 | ||
| 020 | _a0824785959 (alk. paper) | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC _dBD-DhNUB |
||
| 082 | 0 | 0 |
_a615.19 _222 _b1 |
| 100 | 1 |
_aCocchetto, David M., _d1953- _978 |
|
| 245 | 1 | 0 |
_aManaging the clinical drug development process / _cDavid M. Cocchetto, Ronald V. Nardi. |
| 260 |
_aNew York : _bDekker, _cc1992. |
||
| 300 |
_axiv, 217p. : _bill. ; _c22 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrug development _xManagement. _979 |
|
| 650 | 0 |
_aDrugs _xResearch _xManagement. _980 |
|
| 650 | 0 |
_aDrugs _xEffectiveness _xEvaluation. _981 |
|
| 650 | 2 |
_aClinical Trials. _982 |
|
| 650 | 2 |
_aDrug Industry _xOrganization & Administration. _983 |
|
| 700 | 1 |
_aNardi, Ronald V. _984 |
|
| 942 |
_2ddc _cBK |
||
| 952 |
_p3010059305 _r2011-12-15 _40 _00 _bNUBML _10 _o615.19 _d2015-03-07 _t1 _zAvailable for reference _70 _2ddc _yBK _aNUBML |
||
| 999 |
_c534 _d534 |
||
| 952 |
_p3040059308 _40 _00 _bNUBML _10 _o615.19 1 _d2015-03-07 _t2 _zAvailable _70 _2ddc _yBK _aNUBML |
||
| 952 |
_p3040059307 _40 _00 _bNUBML _10 _o615.19 1 _d2015-03-07 _t3 _zAvailable _70 _2ddc _yBK _aNUBML |
||
| 952 |
_p3040039310 _40 _00 _bNUBDL _10 _o615.19 1 _d2015-03-07 _t4 _zAvailable _70 _2ddc _yBK _aNUBDL |
||